🦊/Investors

4Bio Ventures

Venture capital

London · 3 people tracked

Find your way into 4Bio Ventures

Fox Verdict
Sign up to see your fit

Fund manager profile

4Bio Ventures is a venture fund manager based in London. SEC filings show 1 venture fund on record, most recently 4Bio Ventures III LP ($200M offering) filed September 2024.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
London
Founded
2022
Tracked investments
2

Team · 3 people

from public directories
Andrey Kozlov· Promoter

What they invest in

from 2 of 2 portfolio companies

Biotech ×2Deep Tech ×1Medical Devices ×1

HQs:United States×2

Investments · 2 tracked

founders shown can be your intro path

By year:2025 · 12023 · 12 dated

NV Therapeuticsnvtx.bioinMar 2025SEC filingmedium confidence

NV Therapeutics develops non-viral gene therapies designed to be safe, effective, and scalable.

BiotechDeep TechMedical DevicesBerkeley, US

Jake Lamson(Co-Founder & Director of Synthetic Biology)Adrian Thrasher(Scientific Co-Founder & Advisor)Donald Kohn(Scientific Co-Founder & Advisor)Giorgia Santilli(Scientific Co-Founder & Advisor)Dima Kuzmin(Board Director & Scientific Co-Founder)inKevin Holden(CEO & Co-Founder)in

Board seatDmitry Kuzmin· per SEC Form D · $7.5M raise · filed Mar 2025

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ray Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is 4Bio Ventures located?
4Bio Ventures is headquartered in London.

Featured in lists